Missling Christopher U

Avg. Two Year Performance

13% Avg. Purchase Return
6% Compound
34% Avg. Sale Return
16% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return7%18%(< 1%)(5%)13%
Purchase Success Rate3 of 63 of 62 of 63 of 63 of 6
Average Sale Return15%20%37%25%34%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2
Drugs » Biotechnology

President and CEO, Director:

Holdings: 1.25M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Sr. VP, Strategic Planning:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--